Khan Najat sold RXRX
March 9, 2026 · Form 4 insider transaction
Khan Najat sold 28,298 shares of Recursion Pharmaceuticals, Inc. at $3.35 per share, a transaction worth $94.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2025; This transaction was executed in multiple trades at prices ranging from $3.32 to $3.405. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.